Please login to the form below

Not currently logged in
Email:
Password:

Syneos Health announces partnership with AiCure

Will leverage proprietary intelligent software and AI-driven insights

Syneos Health

Syneos Health, an integrated biopharmaceutical solutions organisation, has partnered with AiCure for smarter clinical trials that optimise patient engagement. 

AiCure is an artificial intelligence and data analytics company, which offers proprietary intelligent software and AI-driven insights.

The partnership will see AiCure leverage Syneos’ behavioural insights-driven product development model, with the aim to capture, analyse and predict patient behaviours influencing clinical trial adherence.

“The AiCure platform aligns with our unique product developmet model that harnesses behavioural insights to unlock real world experiences,” said Alistair Macdonald, chief executive officer of Syneos Health.

“By deploying the AiCure platform to our investigative sites, we create insights-enriched patient communities to advance clinical research,” he added.

Syneos Health will have access to AiCure’s digital biomarker assessments, evaluating facial, verbal, speech and movement variables to objectively study known clinical endpoints.

The platform identifies adherence patterns and variations in site and participant engagement, providing the opportunity to modify behaviours that increase compliance for the improvement of overall trial success.

Part of this includes providing patients with a smartphone application to guide and confirm proper administration in real-time – as opposed to self-reporting measures.

“Syneos Health’s scale as a leading global CRO, and the largest contract commercial organisation, will enable valuable customer engagements and expands our reach with biopharmaceutical companies of all sizes,” said Adam Hanina, chief executive officer of AiCure

13th November 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics